
    
      Design: parallel cluster pragmatic randomized controlled trial. The study includes patients
      users of a community pharmacies, who meet the following inclusion criteria: patient who
      starts treatment of any of the following pathologies: Chronic Obstructive Pulmonary Disease
      (COPD), Arterial Hypertension or Diabetes Mellitus in Andalusia (Spain).

      In order to avoid possible contamination between patients assigned to the control and
      intervention group, randomization will be carried out at the pharmacy level; preventing the
      pharmacist from applying part of the intervention to the control group.

      Interventions: patients randomized: (i) current practice; or (ii) ANM intervention thru a
      pharmacist delivered support for a newly prescribed medicine.
    
  